Prostate Cancer Treatment in the East Bay: Oakland, Walnut Creek, Fremont, and Beyond

By Ankit Agarwal, MD

Being diagnosed in the East Bay

Many East Bay men tell me the same thing after a prostate cancer diagnosis: “I know there are major centers across the Bay, but I would rather not spend the next month driving back and forth unless I truly need to.” That is a completely reasonable concern.

From Oakland and Berkeley to Walnut Creek, Fremont, Hayward, San Ramon, and Concord, patients often want access to specialized care without unnecessary bridge traffic, parking stress, or repeated long commutes.

That is why I think the East Bay conversation should be practical from the beginning. Which treatment fits the cancer? Which treatment fits your life? And can you receive that care close enough to home that the process remains manageable?

Understanding your diagnosis

Before talking about treatment, I want patients to understand their risk category clearly. PSA, Gleason Grade Group, MRI findings, the number of involved biopsy cores, and baseline urinary function all matter.

Those details drive whether active surveillance, surgery, brachytherapy, SBRT, or combination treatment should be considered. Two men can both hear the words “prostate cancer” and still need very different plans.

Why many East Bay men ask about brachytherapy

Brachytherapy is one of the most effective and efficient radiation options we have for prostate cancer. In low-dose-rate brachytherapy, small radioactive seeds are placed directly into the prostate during an outpatient procedure, allowing focused treatment with a short overall time commitment.

For selected low-risk and intermediate-risk patients, brachytherapy alone can be an excellent option. For selected higher-risk patients, it may be used as part of combined treatment with external beam radiation and hormone therapy.

For men who are candidates for monotherapy, there are also substantial data behind the approach. In a multi-institutional analysis of 9,101 men treated with low-dose-rate brachytherapy alone, Pd-103 was associated with a 7-year freedom from biochemical failure rate of 96.2%, compared with 87.6% for I-125. That kind of detail matters because it shows that brachytherapy is not one generic treatment – technique, isotope choice, and experience all matter.

One reason East Bay patients often find it appealing is simple: the treatment burden can be much lower than a long course of daily radiation. That matters for men balancing work, caregiving, commuting, and normal life.

It is not the right treatment for every patient, and I try to be very direct about that. Prior TURP, larger gland size, baseline urinary issues, and other anatomic factors can change the recommendation. The value of the consultation is figuring that out carefully.

A practical East Bay treatment pathway

In many cases, the first step is consultation and record review, followed by a decision about whether you are better served with surveillance, surgery consultation, brachytherapy, SBRT, or a combined plan.

For East Bay patients, local access can make a real difference. We care for patients through locations in Danville and procedural sites in Oakland, Walnut Creek, Fremont, and Tracy, which can reduce the need to cross the Bay repeatedly for every step of treatment.

Hormone therapy and treatment de-escalation

For higher-risk disease, androgen deprivation therapy can still be important, but one of the major advances in recent years has been moving toward more individualized treatment intensity.

When brachytherapy is part of the plan in selected patients, the discussion around hormone therapy duration can become more nuanced. That is one reason I think higher-risk patients benefit from hearing from a team that routinely considers all of the major radiation approaches together.

The TRIP/TRIGU0907 phase 3 trial is one example. In 332 men treated with brachytherapy plus external beam radiation, the 7-year cumulative incidence of biochemical progression was 9.0% with shorter-course ADT and 8.0% with longer-course ADT, without a significant difference between the groups. For East Bay patients who are still working, commuting, or trying to preserve quality of life, that is not an abstract statistic – it can translate into far fewer months living with hormone-related side effects.

I have also seen this difference personally in follow-up. Some men are most relieved not just by the cancer control, but by being able to get through treatment without feeling that the therapy took over their life.

SBRT and external beam radiation

Not every East Bay patient is a brachytherapy candidate, and external beam radiation remains an excellent option for many men. SBRT can be especially attractive when a patient wants a shorter course than traditional multi-week treatment.

Modern planning, image guidance, and rectal spacing techniques can help improve safety and convenience, and the right recommendation depends on the anatomy and goals of the individual patient.

Local access matters

I grew up in Fremont, and I know how different East Bay travel can feel compared with the Peninsula or San Francisco. A treatment plan that looks straightforward on a map can feel very different once bridge traffic, parking, and work schedules are added in.

That is why I think local access should be part of the medical conversation. Men from Oakland, Berkeley, Walnut Creek, Lafayette, Danville, San Ramon, Fremont, Union City, Hayward, Castro Valley, Pleasanton, Dublin, Concord, Antioch, Richmond, Albany, and nearby communities should know that specialized care can still be practical.

Our team at Western Radiation Oncology

At Western Radiation Oncology, our prostate cancer team focuses heavily on radiation-based treatment planning, including brachytherapy and SBRT. Experience matters because patient selection and side-effect counseling are nuanced.

My own goal is to help each patient understand not just what can be done, but what is most sensible for his disease, anatomy, schedule, and long-term quality of life.

Next steps

If you live in the East Bay and have been diagnosed with prostate cancer, I encourage you to gather your PSA history, biopsy report, MRI, medication list, and questions before your consultation. The first visit should help clarify the risk category, the realistic treatment options, and whether a second opinion changes the plan.

Second opinions are welcome. Whether you ultimately choose care with us or elsewhere, the goal should be to make the decision with a full understanding of both the oncologic results and the practical realities of treatment.

About the Author

Dr. Ankit Agarwal is a board-certified radiation oncologist at Western Radiation Oncology who specializes in prostate cancer treatment, including brachytherapy, SBRT, and combined-modality care. He serves patients throughout the East Bay and the broader Bay Area.